What is DA Davidson's Estimate for Medifast Q1 Earnings?

Medifast, Inc. (NYSE:MED - Free Report) - Equities research analysts at DA Davidson issued their Q1 2025 earnings per share (EPS) estimates for Medifast in a note issued to investors on Thursday, February 20th. DA Davidson analyst L. Weiser anticipates that the specialty retailer will earn ($0.32) per share for the quarter. DA Davidson currently has a "Neutral" rating and a $16.50 price objective on the stock. The consensus estimate for Medifast's current full-year earnings is $0.51 per share. DA Davidson also issued estimates for Medifast's FY2026 earnings at $0.50 EPS.

Medifast (NYSE:MED - Get Free Report) last posted its quarterly earnings data on Tuesday, February 18th. The specialty retailer reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.26. Medifast had a net margin of 0.35% and a return on equity of 10.64%. The firm had revenue of $119.00 million for the quarter, compared to analysts' expectations of $114.25 million.

Medifast Price Performance

NYSE MED traded down $0.35 on Monday, hitting $13.99. 209,029 shares of the stock were exchanged, compared to its average volume of 231,781. Medifast has a 52-week low of $13.57 and a 52-week high of $41.60. The company has a market capitalization of $152.98 million, a price-to-earnings ratio of 77.70 and a beta of 1.14. The company's 50-day moving average price is $15.94 and its two-hundred day moving average price is $17.80.

Hedge Funds Weigh In On Medifast

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. JPMorgan Chase & Co. grew its holdings in shares of Medifast by 156.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 57,455 shares of the specialty retailer's stock valued at $1,100,000 after acquiring an additional 35,017 shares in the last quarter. Centiva Capital LP grew its holdings in shares of Medifast by 6.3% during the 3rd quarter. Centiva Capital LP now owns 15,238 shares of the specialty retailer's stock valued at $292,000 after acquiring an additional 898 shares in the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of Medifast by 2,308.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer's stock valued at $202,000 after acquiring an additional 10,967 shares in the last quarter. Quarry LP grew its holdings in shares of Medifast by 148.6% during the 3rd quarter. Quarry LP now owns 6,629 shares of the specialty retailer's stock valued at $127,000 after acquiring an additional 3,962 shares in the last quarter. Finally, FMR LLC grew its holdings in shares of Medifast by 44.6% during the 3rd quarter. FMR LLC now owns 30,786 shares of the specialty retailer's stock valued at $589,000 after acquiring an additional 9,499 shares in the last quarter. 95.51% of the stock is currently owned by hedge funds and other institutional investors.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.